Merck and River Blindness

Merck and River Blindness - Merck and River Blindness...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Merck and River Blindness Significant Facts: Onchocerciasis (river blindness) effects 20m people (mainly in Saharan Africa) 100m people are at risk of being afflicted Merck one of the largest pharmaceutical companies, produced avermectins to combat the illness Avermectins (now called Mectizan) was found effective when tested on horses Vagelos (CEO 1985, Merck) announced that Merck will donate the drug to all who needed it for as long as it took to eradicate the disease Distribution in the hands on Onchocerciasis Control Programme (OCP) By 2003, Merck had donated 250m doses Costs = $1.50 per person Up to 15 years of treatment needed to eliminate the worm from its host. Assumption: The cost of donating the drug to people who have Onchocerciasis will be absorbed by Merck’s customers. Stakeholders or Interested Parties: $1.50 per person annually x 20m people affected= $30,000,000 x 15 years = $450,000,000 Customers of Merck products may have to absorb this cost
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 09/08/2010 for the course BUS 186 at San Jose State University .

Page1 / 2

Merck and River Blindness - Merck and River Blindness...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online